Skip to main content
. 2022 Apr 27;13:871564. doi: 10.3389/fimmu.2022.871564

Figure 1.

Figure 1

Transcriptome and proteome levels of m6A regulators and clinical parameters in low-grade gliomas (LGG). (A) Genetic alteration profiles of the studied m6A modification regulators from 529 patients with LGG. (B, C) Violin diagrams of expression levels of the m6A regulators (normal sample vs tumor sample) (B) and (primary LGG vs recurrent LGG) (C) from TCGA database. (D) Immunohistochemistry staining of m6A RNA regulators in LGG retrieved from Human Protein Atlas.